Dark Mode
Friday, 22 November 2024
Logo
Prince Charles to open AstraZeneca research and development facility on Tuesday
UK-Royal Family-Prince Charles/The Royal Family official Facebook page

The NDTV reported according to Reuters, Britain's Prince Charles will formally open a new 1 billion pound ($1.3 billion) AstraZeneca research and development (R&D) facility on Tuesday, as the company aims to fuel the growth of its drug pipeline.


AstraZeneca has supplied two billion doses of its COVID-19 vaccine, developed at Oxford University, and is also looking to bring a preventative antibody cocktail against COVID-19 to market.


But while the company is setting up a separate division for vaccine and antibody therapies in light of the coronavirus pandemic, it has also strengthened other areas of research




AstraZeneca vaccine/Pixabay AstraZeneca vaccine/Pixabay

Earlier this year, AstraZeneca completed the $39 billion purchase of rare-disease specialist Alexion.


Read more: At least 45 people died after bus crashed and caught fire in western Bulgaria


Chief Executive Pascal Soriot said in a statement: "Our new Discovery Centre in Cambridge raises the bar for sustainable R&D and global collaboration across our industry."


"It will allow us to break new boundaries in the understanding of disease biology, bring life-changing medicines to patients and power the next stage of our company's growth."


Read more: UK announces to host G7 foreign and development ministers next month in Liverpool


AstraZeneca, which has a large portfolio of treatments for diseases like cancer, heart disease and diabetes, said the centre would support research into specialised medicines and next-generation therapeutics, including gene-editing and cell therapies.


Prince Charles, son of Queen Elizabeth and heir to the throne, will take a walking tour of the centre and give a short address at the opening.


Source: ndtv